Pharmacology Flashcards

1
Q

Initial enzyme-substrate interactions in active sites are typically ________

A

Non covalent (H-bonding, VDW, hyrdophobic, electrostatic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Active site excludes ______

A

bulk solvent which would reduce cat.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Species Specificity (differential)

A

The likeliness of a drug to attack enzyme isoform in one species while leaving the host alone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Two fundamental phenomena behind drug resistance

A
  1. reduced intracellular concentration of drug

2. changes in drug target

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

A flexible drug avoids

A

Drug resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What mechanisms may cause reduced intracelluar concentration of a drug?

A

Drug inactivation, Prevention of drug uptake, Drug efflux

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What mechanisms are classisfied as target-based mechanisms

A

Altered drug target (receptor mutates), Bypassing metabolic requirements, insensitivity to apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Activation of the receptor to signal as a result of binding

A

Agonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Drugs that bind to a receptor and block agonist from binding

A

antagonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Bind to an active receptor and turn it to an inactive/tense for

A

inverse agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pro-drug

A

utilizes a specific enzyme to transform inactive molecule to active form in vivo.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Why use a pro-drug?

A

When absorption/cell permeation or manufacturing are issues. Also, used to target specific tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pharmacodynamic DDI

A

a drug-drug interaction that occurs at the receptor [additive, synergistic, antagonistic] (e.g. competitive inhibitor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pharmacokinectic DDI

A

Affects the metabolism, absorption, excretion, or distribution of the drug.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Suicide Inhibitors

A

bind covalently to the enzyme and reders it ineffective.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Two phases of drug metabolism

A

(1) reactions (Redox, hydrolysis) to increase aqueous solubility accerates elimination
(2) reactions conjugate drug or metabolite to an endogenous substrate (acetice acid, amino acid, etc.)

17
Q

PM

A

poor metabolizers

18
Q

EM

A

extensive metabolizers

19
Q

IM

A

intermediate metabolizers

20
Q

Acute drug toxicity will most likely affect what organs?

A

liver, kidney, brain, heart

21
Q

Between an inhibitor and an inducer, which effects would be seen first?

A

Inhibitor. Inducer must bind to a promoter and upregulate protein synthesis at a target gene. (exception - suicide inhibitor)

22
Q

Ligand-Receptor binding creates

A

Hyperbolic saturation binding curve

23
Q

Enzyme Reaction creates

A

Hyperbolic Michaelis-Menten Plot

24
Q

Positive cooperativity

A

refers to ligand-receptor, increases binding aff. of OTHER SUBUNITS

25
Q

Allosteric activation

A

refers to enzyme reactions, increase affinity of active site on SAME SUBUNIT

26
Q

Negative cooperativity

A

ligand-receptor, decrease binding ability on OTHER SUBUNITS

27
Q

Allosteric inhibition

A

enzyme reaction, decreases binding ability on SAME SUBUNITS